News & Trends - Pharmaceuticals
First Australian site joins AstraZeneca’s phase 3 breast cancer trial
Australia’s first site joins an international breast cancer clinical trial aimed at determining whether AstraZeneca’s next-gen hormone treatment can provide […]
MoreNews & Trends - MedTech & Diagnostics
Australians lack trust in politicians and mainstream media as ethics index hits new low
Australians have ranked health as the most ethical sector (64) and mainstream broadcast media as the least ethical (–10), according […]
MoreNews & Trends - Biotechnology
First national summit calls for unified strategy to reshape local biotech and medtech sectors
The National Biotech and Medtech Development and Commercialisation Summit 2024 convenes today in Canberra, bringing together over 100 of Australia’s […]
MoreDigital & Innovation
AI partnership to propel launch of National Lung Cancer Screening Programme
Digital & Innovation: Starting July 2025, the Australian Government will fund the National Lung Cancer Screening Programme (NLCSP), a crucial […]
MoreLeadership & Management
Lundbeck appoints new Managing Director in ANZ
Leadership & Management: Lundbeck has named Cara Dignum as the new Managing Director for Lundbeck Australia and New Zealand, succeeding […]
MoreESG
Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities
Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]
MoreHuman Resources
Women still earn $28K less than men despite progress
Australia’s total remuneration gender pay gap has narrowed by 0.6 percentage points, with more employers analysing and addressing the underlying […]
MoreMedical and Science
Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps
Former deputy secretary of the Department of Health, Rosemary Huxtable AO PSM, has been appointed to spearhead the development of […]
MoreCommunication
Australians’ trust in mainstream health media is in crisis
Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
First Australian site joins AstraZeneca’s phase 3 breast cancer trial
November 21, 2024
in News & Trends - Pharmaceuticals
Australians lack trust in politicians and mainstream media as ethics index hits new low
November 21, 2024
in News & Trends - MedTech & Diagnostics
Amgen secures PBS listing for the only dual-action first-line therapy in osteoporosis
November 21, 2024
in News & Trends - Pharmaceuticals
Aussie researchers expand high cholesterol treatments with game-changing data unveiled on global stage
November 21, 2024
in News & Trends - Pharmaceuticals
Health Minister announces HTA reform advisory group as questions persist over timelines and transparency
November 20, 2024
in News & Trends - Pharmaceuticals
Fix it once and for all: Viatris country manager calls for action on medicine shortages and sovereign manufacturing
November 20, 2024
in News & Trends - Pharmaceuticals
Australia risks missing $1 billion windfall without biosimilar action
November 20, 2024
in News & Trends - Pharmaceuticals
Women still earn $28K less than men despite progress
November 20, 2024
in Human Resources
Government urged to prioritise prevention as chronic disease costs surge by $13 billion
November 20, 2024
in News & Trends - Pharmaceuticals
Boston Scientific unveils superiority data in bleeding risk reduction post-cardiac ablation
November 19, 2024
in News & Trends - MedTech & Diagnostics
Getz Healthcare signs distribution agreement for electrochemotherapy technology
November 19, 2024
in News & Trends - MedTech & Diagnostics
Will the BMS Summit challenge government to act on HTA reforms amid competing priorities?
November 19, 2024
in News & Trends - Pharmaceuticals
First national summit calls for unified strategy to reshape local biotech and medtech sectors
November 19, 2024
in News & Trends - Biotechnology
‘Government’s broken promises in the health portfolio are piling up,’ says Shadow Health Minister Ann Ruston
November 18, 2024
in News & Trends - Pharmaceuticals
Boston Scientific acquires Medtronic’s neuromodulation competitor
November 18, 2024
in News & Trends - MedTech & Diagnostics
Doctors accused of fraudulent billing while health insurers pocket record profits
November 18, 2024
in News & Trends - MedTech & Diagnostics
Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps
November 18, 2024
in Medical and Science
Aussie biotech nabs award for needle-free vaccine technology
November 18, 2024
in News & Trends - Biotechnology
Horizon scanning report exposes critical systemic gaps demanding immediate reform
November 15, 2024
in News & Trends - Pharmaceuticals
Follow Us
Partner with us
News & Trends - Pharmaceuticals
First Australian site joins AstraZeneca’s phase 3 breast cancer trial
Australia’s first site joins an international breast cancer clinical trial aimed at determining whether AstraZeneca’s next-gen hormone treatment can provide […]
MoreNews & Trends - MedTech & Diagnostics
Australians lack trust in politicians and mainstream media as ethics index hits new low
Australians have ranked health as the most ethical sector (64) and mainstream broadcast media as the least ethical (–10), according […]
MoreNews & Trends - Pharmaceuticals
Amgen secures PBS listing for the only dual-action first-line therapy in osteoporosis
Amgen’s humanised monoclonal antibody has become the first osteoanabolic agent with a dual mode of action to be listed on […]
MoreNews & Trends - Pharmaceuticals
Aussie researchers expand high cholesterol treatments with game-changing data unveiled on global stage
Monash University and Monash Health are collaborating on two clinical trials to develop the first effective drug treatments for two […]
More